The value of Dagla as an anti-obesity target would be enhanced if the favorable metabolic phenotype shared by Dagla and Cnr1 KO mice was not linked to the undesirable neuropsychiatric effects associated with rimonabant. The gene discussed is DAGLA; the disease is obesity due to melanocortin 4 receptor deficiency.